Needed: A Life Course Perspective on Maintaining Pre-exposure Prophylaxis Use.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice.Current HIV/AIDS reports · 2024
   Review
2. Supporting the Art: Medication Adherence Patterns in Persons Prescribed Ingestible Sensor-enabled Oral Pre-Exposure Prophylaxis to Prevent Human Immunodeficiency Virus Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
   Article
3. Predictors of Re-Initiation of Daily Oral Preexposure Prophylaxis Regimen After Discontinuation.AIDS and behavior · 2022
   Article

Corrections and comments

• Comment on
  Persistence With Human Immunodeficiency Virus Pre-exposure Prophylaxis in the United States, 2012-2017.2021

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as